Life Sciences
Studies from University of Nottingham yield new data on life sciences
Published in Telemedicine Business Week, June 25th, 2008
"The selective cyclooxygenase-2 inhibitor lumiracoxib has been shown to reduce endoscopically detected ulcers and ulcer complications in the upper gastrointestinal tract compared with nonselective nonsteroidal anti-inflammatory drugs. We investigated whether lumiracoxib would reduce small-bowel injury compared with naproxen plus omeprazole," scientists writing in the journal Clinical Gastroenterology and Hepatology report.
"Healthy volunteers were randomized to receive lumiracoxib, 100 mg once daily, naproxen 500 mg twice daily plus omeprazole 20 mg once daily, or placebo in a 16-day double-blind, parallel-group study. Small-bowel mucosal injury and inflammation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Acid Reflux Disease
New acid reflux disease research from H. Miwa and colleagues discussed - Addiction Medicine
Baylor College of Medicine, College of Medicine publishes research in addiction medicine - Adenocarcinoma
Research from M. Akcaer and co-researchers yields new findings on adenocarcinoma - Adenocarcinoma Therapy
Research on adenocarcinoma therapy discussed by S. Bogaerts and co-researchers - Adrenalectomy
Research reports on adrenalectomy from Niguarda Hospital, Department of Surgery provide new insights - Advanced Photonix, Inc.
Advanced Photonix, Inc. Announces T-Ray 4000 Terahertz System Orders from Major Research Institutions - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
